Artificial Vital Organs Market
Artificial Vital Organs Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Artificial Vital Organs Market Size and Growth
The Artificial Vital Organs market is experiencing significant growth, driven by advancements in technology and increasing organ transplant shortages. As of 2023, the market size is estimated to exceed $10 billion, with a projected CAGR of over 15% through the next five years, highlighting the urgency for innovative solutions in healthcare.
Companies Covered
(Covid 19 Impact Covered)
◍ Edwards Lifesciences Corporation
◍ Abbott Diabetes Care
◍ Baxter International
◍ Ekso Bionics
◍ Asahi Kasei Medical
◍ Jarvik Heart
◍ Ottobock Healthcare
The artificial vital organs market features companies like Edwards Lifesciences, Abbott, and Baxter, focusing on advanced devices like heart valves, diabetes management tools, and dialysis systems. They drive market growth through innovation and partnerships. Selected revenue figures include:
- Edwards Lifesciences: $5.24 billion (2022)
- Abbott: $43 billion (2022)
- Baxter: $13.1 billion (2022)
Request Sample Report
Market Segmentation
By Application
◍ Research Centers ◍ Others
By Product
Others ◍ Hospitals ◍ Clinics
◍ Artificial Liver ◍ Artificial Heart ◍ Artificial Pancreas ◍ Artificial Kidney
Artificial Lungs
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
